What You Should Know
The Launch: Amazon Pharmacy has officially expanded its weight management portfolio by adding Eli Lilly's Zepbound® KwikPen® to its digital shelves.The Hardware: Unlike traditional single-use GLP-1 auto-injectors, the KwikPen is a multi-dose device designed to deliver a full month of medication in a single pen, reducing medical waste and simplifying the patient experience.The Disruption: Bypassing the murky world of Pharmacy Benefit Managers (PBMs), Amazon is offering
Read More
GLP-1
Walgreens Launches Virtual Weight Management Platform for Self-Pay GLP-1 Patients
What You Should Know
The Launch: Walgreens has expanded its virtual healthcare platform to include Walgreens Weight Management, a digital clinic connecting eligible adults (18-64) with doctors or nurse practitioners to obtain FDA-approved weight loss medications.The Pricing Model: In a direct shot at subscription-heavy telehealth competitors, Walgreens is charging a flat $49 per visit with zero monthly subscription fees.The Target Audience: The service is explicitly designed for the
Read More
How Employers Can Save $550/Month on GLP-1s: Introducing Vida Self-Pay
What You Should Know
- Vida Health has partnered with RxSaveCard to launch Vida Self-Pay, a first-of-its-kind platform that bypasses traditional PBM markups for anti-obesity medications (AOMs).
- By combining virtual, whole-person clinical care with transparent "cash-price" subsidies, the partnership enables employers to save up to $550 per member per month while expanding access to GLP-1s and other AOMs.
Bypassing the PBM "Walled Garden"
The Vida Self-Pay model functions as a
Read More
Noom Pivots to Longevity: New Program Combines Microdose GLP-1s with At-Home Biomarker Testing
What You Should Know:
- Noom has launched Proactive Health Microdose GLP-1Rx, a first-of-its-kind preventive health program designed to intervene before chronic disease takes root.
- Available to individuals with a BMI of 21 or higher, the offering combines personalized microdoses of GLP-1 medication with comprehensive at-home biomarker testing and Noom’s digital behavior modification platform.
- Priced at $149 per month, the program aims to shift the healthcare paradigm
Read More
PHTI Report 2025: 5 Strategies for Employers to Manage GLP-1 Costs and Coverage
What You Should Know:
- The Peterson Health Technology Institute (PHTI) has released a critical purchasing guide for employers struggling to manage the skyrocketing costs of GLP-1 obesity medications.
- The report recommends a shift away from broad, unchecked coverage toward a managed approach focused on three phases: Initiation (strict eligibility), Maintenance (adherence support), and Supported Discontinuation (managing off-ramps).
- PHTI urges employers to demand
Read More
Castlight and Noom Join Forces to Tackle the GLP-1 Cost Crisis Through Integrated Digital Health
What You Should Know:
- Castlight Health and Noom have formed a strategic partnership to embed Noom’s preventive health and weight management programs directly into Castlight’s health navigation platform.
- The integration allows employers to purchase Noom through Castlight, granting employees seamless access to psychology-based care and GLP-1 medication management. The move is designed to combat rising healthcare costs by pairing expensive pharmaceutical interventions with
Read More
Dietitian Live’s Quantum Mind Architecture™: How Subconscious Rewiring is Reversing Type 2 Diabetes Without GLP-1s
What You Should Know:
- Dietitian Live, a pioneering healthcare startup, today announced a breakthrough demonstrating that subconscious belief patterns are the primary driver of healing in chronic metabolic disease.
- Its patent-pending Quantum Mind Architecture™ program achieved an 81% reversal to normal A1C levels in pre-diabetes and 28% reversal in Type 2 Diabetes without GLP-1s in a same-cohort study. The company is advocating for the creation of a new field: subconscious
Read More
GoodRx Launches $199 Ozempic and Wegovy Pricing, Unveils Telemedicine for GLP-1 Access
What You Should Know:
- GoodRx has unveiled two major initiatives to democratize access to GLP-1 medications: the launch of the GoodRx for Weight Loss telemedicine subscription and a new introductory cash price of $199 per month for Ozempic® and Wegovy® injection pens through a partnership with Novo Nordisk.
GoodRx for Weight Loss Telemedicine
GoodRx for Weight Loss, a direct-to-consumer telemedicine subscription is designed to simplify and manage every step of the GLP-1 treatment
Read More
Trump Unveils Historic Drug Price Cuts: Ozempic and Wegovy Reduced to $350 via TrumpRx
What You Should Know:
- President Donald J. Trump announced the latest in a series of significant actions to lower prescription drug prices, unveiling agreements with pharmaceutical manufacturers Eli Lilly and Company and Novo Nordisk.
- The initiative delivers historic price reductions on some of the world’s most popular drugs, impacting millions of Americans struggling with chronic diseases, diabetes, heart disease, and obesity.
Price Reductions for Patients and
Read More
Evolv Launches GLP-1 Supplement, a Natural Alternative to Weight-Loss Drugs
What You Should Know:
- Pioneering biomimetics company Evolv introduces its first product Evolv GLP-1: the first ingestible, natural GLP-1 peptide designed for effective and accessible weight management
- The oral GLP-1 supplement was created using a proprietary yeast strain engineered to produce a new molecule that delivers the full power of GLP-1 naturally. Unlike synthetic drugs, this non-habituating supplement is designed to help individuals manage appetite and metabolism without
Read More
